Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

NCT02221479

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Investigational Site Number 392105 Kamogawa-Shi, Japan
  • Investigational Site Number 392103 Kyoto, Japan
  • Investigational Site Number 392102 Nagoya, Japan
  • Investigational Site Number 392104 Okayama, Japan
View Trial Details
Completed

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma

NCT01508416

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +14 more
Locations
  • CHU de Clermont Ferrand Clermont-Ferrand, France
  • CHU de Nancy Nancy, France
  • Service de Médecine Interne - CHU de Saint Etienne Saint-Etienne, France
  • Service de rhumatologie - CHU de Saint Etienne Saint-Etienne, France
View Trial Details
Completed

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

NCT00131261

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • James Berenson, MD, Inc West Hollywood, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Research Facility New York, United States
View Trial Details
Completed

A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib

NCT00689507

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • UCLA Los Angeles, California, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions